Evolution of the coronavirus spike protein in the full-length genome and defective viral genome under diverse selection pressures
Open Access
- 24 November 2023
- journal article
- research article
- Published by Microbiology Society in Journal of General Virology
- Vol. 104 (11) , 001920
Abstract
How coronaviruses evolve by altering the structures of their full-length genome and defective viral genome (DVG) under dynamic selection pressures has not been studied. In this study, we aimed to experimentally identify the dynamic evolutionary patterns of the S protein sequence in the full-length genome and DVG under diverse selection pressures, including persistence, innate immunity and antiviral drugs. The evolutionary features of the S protein sequence in the full-length genome and in the DVG under diverse selection pressures are as follows: (i) the number of nucleotide (nt) mutations does not necessarily increase with the number of selection pressures; (ii) certain types of selection pressure(s) can lead to specific nt mutations; (iii) the mutated nt sequence can be reverted to the wild-type nt sequence under the certain type of selection pressure(s); (iv) the DVG can also undergo mutations and evolve independently of the full-length genome; and (v) DVG species are regulated during evolution under diverse selection pressures. The various evolutionary patterns of the S protein sequence in the full-length genome and DVG identified in this study may contribute to coronaviral fitness under diverse selection pressures.Keywords
Funding Information
- National Science and Technology Council (109-2313-B-005 -013 -MY3, 110-2327-B-005 -003 and 111-2327-B-005 -003)
This publication has 49 references indexed in Scilit:
- Preexisting drug-resistance mutations reveal unique barriers to resistance for distinct antiviralsProceedings of the National Academy of Sciences, 2011
- Phenotypic and genotypic characterization of influenza virus mutants selected with the sialidase fusion protein DAS181Journal of Antimicrobial Chemotherapy, 2010
- Resistance profile of the new nucleoside reverse transcriptase inhibitor apricitabineJournal of Antimicrobial Chemotherapy, 2009
- Evolutionary Trends of A(H1N1) Influenza Virus Hemagglutinin Since 1918PLOS ONE, 2009
- SARS coronavirus spike protein-induced innate immune response occurs via activation of the NF-κB pathway in human monocyte macrophages in vitroVirus Research, 2009
- The emerging field of HCV drug resistanceExpert Opinion on Investigational Drugs, 2008
- Severe outbreak of bovine coronavirus infection in dairy cattle during the warmer seasonVeterinary Microbiology, 2008
- Nidovirales: Evolving the largest RNA virus genomeVirus Research, 2006
- Isolation and Characterization of Viruses Related to the SARS Coronavirus from Animals in Southern ChinaScience, 2003
- Virus persistence and recurring demyelination produced by a temperature-sensitive mutant of MHV-4Nature, 1982